Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » Expert Content


Advances in clinical supply models. Innovations in packaging and cold chain distribution. Proven results from our team of clinical supply experts.


Found 40 results in Expert Content

CGMP-Compliant iPSC Manufacturing and Development of Differentiated Cells for Advanced Therapies: Strategies and Challenges
The Current State of the Cell Therapy Market: Q&A with Maria Lopez, General Manager, US Cell Therapy at Catalent Biologics
Exploring a One-Stop Integrated Solution for AAV Vector Clinical Production
GMP Process for High-Quality iPSC Manufacturing and Development of Improved Differentiation Methodologies
Early Phase Support for Plasmid DNA Supply to Secure Future Manufacturing
Catalent’s iPSCs as a Starting Material for Advanced Cell Therapies
Advancing Towards a Universal Platform for iPSC-Based Therapies
Integrated Solutions for Advanced Therapies
Catalent Cell & Gene Therapies – Changing the Healthcare Landscape
Strategic Considerations for Scaling Up the Manufacturing of Cell Therapies